Mark N. Lampert, 10% Owner at LIGAND PHARMACEUTICALS INC (LGND), bought 6,020 shares at $13.91 ($84K) on 2011-10-26, disclosed to the SEC on 2011-10-28.
Open-market purchase of $84k LGND by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.91 | 900 | $13K | 15.0% |
| 2 | $13.91 | 1,320 | $18K | 21.9% |
| 3 | $13.91 | 3,800 | $53K | 63.1% |
| Total | $13.91 avg | 6,020 | $84K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |